The program director of the Medstar Georgetown University Hospital Headache Medicine Fellowship program discussed the potential of INP104 to improve migraine patient care.
Carrie Dougherty, MD, FAHS
Advertisement
Associate professor of neurology, and program director, Headache Medicine Fellowship program, Medstar Georgetown University Hospital
Articles by Carrie Dougherty, MD, FAHS
The program director of the Medstar Georgetown University Hospital Headache Medicine Fellowship program discussed further research to be conducted with the nasal delivery of DHE.
The program director of the Medstar Georgetown University Hospital Headache Medicine Fellowship program discussed the advantages of INP104 over other forms of dihydroergotamine.
The program director of the Medstar Georgetown University Hospital Headache Medicine Fellowship program discussed the findings of the STOP 301 study.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Early Results Show Symptom Gains in First Patient Dosed With UX-DA001 Cell Therapy for Parkinson Disease
2
Understanding Key Clinical and Genetic Biomarkers in Huntington Disease Research: Sarah O'Shea, MD, MSc
3
Using Brain Stimulation to Curb Cannabis Overuse in Multiple Sclerosis
4
Bringing Biomarkers to the Bedside: The Clinical Promise of Abbott’s TBI Test
5
